Eapen MS[au] - Search Results

Year	Number of Results
2007	1
2008	1
2010	1
2015	1
2016	1
2017	9
2018	8
2019	11
2020	11
2021	16
2022	8

1

Therapeutic targets in lung tissue remodelling and fibrosis.

Liu G, Philp AM, Corte T, Travis MA, Schilter H, Hansbro NG, Burns CJ, Eapen MS, Sohal SS, Burgess JK, Hansbro PM. Liu G, et al. Among authors: eapen ms. Pharmacol Ther. 2021 Sep;225:107839. doi: 10.1016/j.pharmthera.2021.107839. Epub 2021 Mar 25. Pharmacol Ther. 2021. PMID: 33774068 Review.

2

The rise of electronic nicotine delivery systems and the emergence of electronic-cigarette-driven disease.

McAlinden KD, Eapen MS, Lu W, Sharma P, Sohal SS. McAlinden KD, et al. Among authors: eapen ms. Am J Physiol Lung Cell Mol Physiol. 2020 Oct 1;319(4):L585-L595. doi: 10.1152/ajplung.00160.2020. Epub 2020 Jul 29. Am J Physiol Lung Cell Mol Physiol. 2020. PMID: 32726146 Free article. Review.

3

Anti-Inflammatory Activity of Fucoidan Extracts In Vitro.

Ahmad T, Eapen MS, Ishaq M, Park AY, Karpiniec SS, Stringer DN, Sohal SS, Fitton JH, Guven N, Caruso V, Eri R. Ahmad T, et al. Among authors: eapen ms. Mar Drugs. 2021 Dec 11;19(12):702. doi: 10.3390/md19120702. Mar Drugs. 2021. PMID: 34940701 Free PMC article.

4

Endothelial to mesenchymal transition (EndMT) and vascular remodeling in pulmonary hypertension and idiopathic pulmonary fibrosis.

Gaikwad AV, Eapen MS, McAlinden KD, Chia C, Larby J, Myers S, Dey S, Haug G, Markos J, Glanville AR, Sohal SS. Gaikwad AV, et al. Among authors: eapen ms. Expert Rev Respir Med. 2020 Oct;14(10):1027-1043. doi: 10.1080/17476348.2020.1795832. Epub 2020 Jul 28. Expert Rev Respir Med. 2020. PMID: 32659128 Review.

5

Diagnostic approaches in COVID-19: clinical updates.

Asrani P, Eapen MS, Chia C, Haug G, Weber HC, Hassan MI, Sohal SS. Asrani P, et al. Among authors: eapen ms. Expert Rev Respir Med. 2021 Feb;15(2):197-212. doi: 10.1080/17476348.2021.1823833. Epub 2020 Sep 30. Expert Rev Respir Med. 2021. PMID: 32924671 Review.

6

Pathogenesis, clinical features of asthma COPD overlap, and therapeutic modalities.

Dey S, Eapen MS, Chia C, Gaikwad AV, Wark PAB, Sohal SS. Dey S, et al. Among authors: eapen ms. Am J Physiol Lung Cell Mol Physiol. 2022 Jan 1;322(1):L64-L83. doi: 10.1152/ajplung.00121.2021. Epub 2021 Oct 20. Am J Physiol Lung Cell Mol Physiol. 2022. PMID: 34668439 Review.

7

Endothelial to mesenchymal transition: a precursor to post-COVID-19 interstitial pulmonary fibrosis and vascular obliteration?

Eapen MS, Lu W, Gaikwad AV, Bhattarai P, Chia C, Hardikar A, Haug G, Sohal SS. Eapen MS, et al. Eur Respir J. 2020 Oct 15;56(4):2003167. doi: 10.1183/13993003.03167-2020. Print 2020 Oct. Eur Respir J. 2020. PMID: 32859681 Free PMC article.

8

Renin-Angiotensin-Aldosterone System Inhibitors in Covid-19.

Haug G, Eapen MS, Sohal SS. Haug G, et al. Among authors: eapen ms. N Engl J Med. 2020 Jun 11;382(24):e92. doi: 10.1056/NEJMc2013707. Epub 2020 May 19. N Engl J Med. 2020. PMID: 32427429 No abstract available.

9

Update on the Pathogenesis of COPD.

Eapen MS, Sohal SS. Eapen MS, et al. N Engl J Med. 2019 Dec 19;381(25):2483-2484. doi: 10.1056/NEJMc1914437. N Engl J Med. 2019. PMID: 31851815 No abstract available.

10

Implications of the second wave of COVID-19 in India.

Asrani P, Eapen MS, Hassan MI, Sohal SS. Asrani P, et al. Among authors: eapen ms. Lancet Respir Med. 2021 Sep;9(9):e93-e94. doi: 10.1016/S2213-2600(21)00312-X. Epub 2021 Jun 30. Lancet Respir Med. 2021. PMID: 34216547 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results